… studies investigating use of its major cancer medicines at ECCO 15 ESMO 34, which opens in Berlin, Germany today. Overall survival benefits will bedemonstrated for Avastin(R) (bevacizumab) in malignant melanoma and for …
…e treatment of patients with metastatic colorectal cancer (mCRC), the world's second most common cancer,was strengthened at the 33rd European Society of Medical Oncology (ESMO) meeting with a compelling data set includin…
… essential for patients with metastatic colorectal cancer (CRC). In total 15 separate data presentations will be made with highlights including:1. Overall survival data confirmed in two large community-based studies,incl…
…07New data from the large international First BEAT trial unveiled today at the European Cancer Conference (ECCO) demonstrate that a high number of patients treated with Avastin plus standard chemotherapy for their colore…
…astin's efficacy and safety in advanced colorectal cancerNew data from 4,000 patients show that Avastin (bevacizumab rhuMAb-VEGF) enables patients with advanced colorectal cancer (CRC) to live longer without progression …
